₹257.35-0.80 (-0.31%)
04:01 PM, 2-Jan-2025₹257.30-0.95 (-0.37%)
03:49 PM, 2-Jan-2025BSE : 543635
NSE : PPLPHARMA
Sector : Health care
ISIN Code : INE0DK501011
Last Updated: 02-Jan-2025 | 09:31 PM IST
Market Cap (₹ Cr.) | 34,118 |
Traded Value (₹ Cr) | 4.18 |
Volume (Shares) | 1,62,578 |
Face Value (₹) | 10 |
52-Week High (₹) | 307.85 |
52-Week High Date | 06-Nov-2024 |
52-Week Low (₹) | 114.45 |
52-Week Low Date | 15-Mar-2024 |
All Time High (₹) | 307.85 |
All Time High Date | 06-Nov-2024 |
All Time Low (₹) | 61.65 |
All Time Low Date | 28-Mar-2023 |
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr.) | 34,112 |
EPS - TTM (₹) [C] | 0.44 |
P/E Ratio (X) [C] | 584.77 |
Face Value (₹) | 10 |
Latest Dividend (%) | 1.10 |
Latest Dividend Date | 12-Jul-2024 |
Dividend Yield (%) | 0.04 |
Book Value Share (₹) [C] | 59.66 |
P/B Ratio (₹) [C] | 4.31 |
Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
---|---|---|---|
Canara Robeco Equity Hybrid Fund (IDCW-M) | 78.47 | 31,50,000 | 0.71 |
Canara Robeco Equity Hybrid Fund (G) | 78.47 | 31,50,000 | 0.71 |
Canara Robeco Equity Hybrid Fund - Direct (G) | 78.47 | 31,50,000 | 0.71 |
Canara Robeco Equity Hybrid Fund - Direct (IDCW-M) | 78.47 | 31,50,000 | 0.71 |
Canara Robeco Balanced Advantage Fund - Dir (IDCW) | 9.84 | 3,95,000 | 0.65 |
Canara Robeco Balanced Advantage Fund - Dir (G) | 9.84 | 3,95,000 | 0.65 |
Canara Robeco Balanced Advantage Fund - Reg (IDCW) | 9.84 | 3,95,000 | 0.65 |
Canara Robeco Balanced Advantage Fund - Reg (G) | 9.84 | 3,95,000 | 0.65 |
Franklin India Pension Plan - (G) | 0.90 | 36,000 | 0.17 |
Franklin India Pension Plan - Direct (IDCW) | 0.90 | 36,000 | 0.17 |
Load more
Today's Low/High (₹) | 253.00 262.70 |
Week Low/High (₹) | 248.35 273.00 |
Month Low/High (₹) | 245.85 284.00 |
Year Low/High (₹) | 114.35 308.00 |
All time Low/High (₹) | 61.65 308.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | 0.00% | -0.02% | 1.87 | 1.85% |
1 Month | -5.73% | -5.91% | -0.38 | -0.36% |
3 Month | 12.48% | 12.45% | -5.13 | -6.23% |
6 Month | 60.06% | 59.97% | 0.63 | 0.27% |
1 Year | 83.07% | 83.13% | 11.20 | 11.64% |
3 Year | % | % | 37.23 | 39.38% |
Chairperson : Nandini Piramal
Executive Director & CEO : PETER D DEYOUNG
Non Executive Director : Neeraj Bharadwaj
Independent Director : Jairaj Purandare
Independent Director : S Rama Dorai
Independent Director : Peter Stevenson
Independent Director : Sridhar Gorthi
Independent Director : Vibha Paul Rishi
Executive Director & CFO : Vivek Valsaraj
Company Sec. & Compli. Officer : Tanya D'Costa
Registered Office: Ground Floor Piramal Ananta, Agastya Corp.Park LBS MargKurl,Mumbai,Maharashtra-400070 Ph: 91-22-3802-3000/4000
1. What's the Piramal Pharma Ltd share price today?
Piramal Pharma Ltd share price was Rs 257.35 at 04:01 PM IST on 2nd Jan 2025. Piramal Pharma Ltd share price was down by 0.31% from the previous closing price of Rs 258.15. Piramal Pharma Ltd share price trend:
2. How can I quickly analyse the performance of the Piramal Pharma Ltd stock?
The performance of the Piramal Pharma Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Piramal Pharma Ltd?
Piramal Pharma Ltd has a market capitalisation of Rs 34,118 crore.
4. What is Piramal Pharma Ltd's 52-week high/low share price?
The Piramal Pharma Ltd’s 52-week high share price is Rs 307.85 and 52-week low share price is Rs 114.45.
5. Is the Piramal Pharma Ltd profitable?
On a consolidated basis, Piramal Pharma Ltd reported a profit of Rs 210.06 crore on a total income of Rs 1,390.77 crore for the quarter ended 2024. For the year ended Sep 2024, Piramal Pharma Ltd had posted a profit of Rs 22.59 crore on a total income of Rs 2,320.12 crore.
6. Which are Piramal Pharma Ltd’s peers in the Health care sector?
Piramal Pharma Ltd’s top 5 peers in the Health care sector are Ipca Labs., Glaxosmi. Pharma, Ajanta Pharma, Piramal Pharma, Laurus Labs, Gland Pharma, J B Chemicals &.
7. Who owns how much in Piramal Pharma Ltd?
Key changes to the Piramal Pharma Ltd shareholding are as follows: